Table 1.
Cerebral malaria n = 12 | Presumed viral encephalitis n = 14 | Controls n = 20 | p-value for multiple comparisons | |
Age (years) | 7.0 (2.7) | 7.0 (3.5) | 1.7 (1.2) | <0.01a |
Gender (male) | 7 | 6 | 9 | nsb |
CSF-parameters: | ||||
White cells (cells/μl)c | 0 (0–3) | 4 (0–9) | 0 (0–4) | <0.01d |
Glucose (mmol/l) | 2.7 (0.3) | 4.2 (0.4) | 3.3 (0.6) | <0.01a |
Protein (g/l) | 0.4 (0.04) | 0.5 (0.06) | 0.3 (0.10) | <0.01a |
CSF-ADA (IU/l) | 4.6 (0.9) | 3.8 (1.0) | 3.3 (0.8) | <0.01a |
Serum ADA (IU/l)c | 14.4 (11.6–17.5) | 6.5 (4.8–10.1) | 6.1 (4.4–8.9) | <0.01d |
Ratio CSF/serum ADA | 0.31 (0.05) | 0.54 (0.11) | 0.53 (0.13) | <0.01a |
CSF-LDH (IU/ml) | 20.7 (2.8) | 26.5 (5.8) | 15.9 (3.8) | <0.01a |
Serum LDH (IU/ml) | 214.1 (25.7) | 247.5 (46.8) | 244.0 (57.7) | ns a |
Ratio CSF/serum LDH | 0.09 (0.02) | 0.11 (0.02) | 0.07 (0.01) | <0.01a |
LDH = Lactic dehydrogenase, ADA = Adenosine deaminase. Results where applicable are given as mean (SD). a Analysis of variance: Post hoc analysis results with p < 0.05 (Tukey HSD test): Age: Cerebral malaria and presumed viral encephalitis versus controls. CSF white cell count: Cerebral malaria versus presumed viral encephalitis and presumed viral encephalitis versus controls. Glucose and protein: Each group versus the 2 other groups. CSF-ADA: Cerebral malaria versus controls. Serum ADA: Cerebral malaria versus the 2 other groups. Ratio CSF/serum ADA: Cerebral malaria versus the two 2 groups. CSF-LDH: Each group versus the other 2 groups. Ratio CSF/serum LDH: Cerebral malaria and presumed viral encephalitis versus controls. b ns = not significant by chi-square test. c Median and range. d Kruskal-Wallis test.